|
1
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
|
Clin Microbiol Infect
|
2012
|
4.56
|
|
2
|
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
|
Bone Marrow Transplant
|
2010
|
3.46
|
|
3
|
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.
|
Clin Infect Dis
|
1997
|
2.78
|
|
4
|
Posaconazole as salvage therapy for zygomycosis.
|
Antimicrob Agents Chemother
|
2006
|
2.65
|
|
5
|
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
|
J Clin Oncol
|
1991
|
1.94
|
|
6
|
Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections.
|
Br J Haematol
|
1998
|
1.84
|
|
7
|
An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group.
|
J Infect
|
1998
|
1.82
|
|
8
|
A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
|
Br J Haematol
|
1997
|
1.59
|
|
9
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).
|
Clin Microbiol Infect
|
2012
|
1.55
|
|
10
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
|
Clin Microbiol Infect
|
2012
|
1.48
|
|
11
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.
|
Clin Microbiol Infect
|
2012
|
1.41
|
|
12
|
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
|
J Clin Oncol
|
1994
|
1.38
|
|
13
|
Forty-one recent cases of invasive zygomycosis from a global clinical registry.
|
J Antimicrob Chemother
|
2009
|
1.31
|
|
14
|
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
|
Ann Oncol
|
1993
|
1.29
|
|
15
|
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment.
|
Hematol J
|
2001
|
1.20
|
|
16
|
Towards novel paradigms for cancer therapy.
|
Oncogene
|
2010
|
1.18
|
|
17
|
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
|
Clin Infect Dis
|
1997
|
1.17
|
|
18
|
Candida catenulata fungemia in a cancer patient.
|
J Clin Microbiol
|
1999
|
1.17
|
|
19
|
A retrospective series of gut aspergillosis in haematology patients.
|
Clin Microbiol Infect
|
2011
|
1.13
|
|
20
|
Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.
|
Transpl Infect Dis
|
1999
|
1.09
|
|
21
|
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma.
|
Ann Oncol
|
2009
|
1.07
|
|
22
|
Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations.
|
Leukemia
|
2012
|
1.07
|
|
23
|
Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.
|
Am J Med
|
1991
|
1.05
|
|
24
|
The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses.
|
Clin Infect Dis
|
1995
|
1.03
|
|
25
|
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
|
Br J Cancer
|
1994
|
1.01
|
|
26
|
LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
|
J Clin Oncol
|
1989
|
1.01
|
|
27
|
Improvement in the outcome of invasive fusariosis in the last decade.
|
Clin Microbiol Infect
|
2013
|
0.99
|
|
28
|
Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.
|
J Infect
|
2006
|
0.97
|
|
29
|
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.
|
J Antimicrob Chemother
|
2009
|
0.96
|
|
30
|
Disseminated Trichosporon capitatum infection in a patient with acute leukemia undergoing bone marrow transplantation.
|
Bone Marrow Transplant
|
1990
|
0.95
|
|
31
|
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
|
Leuk Lymphoma
|
1997
|
0.95
|
|
32
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.
|
Clin Microbiol Infect
|
2012
|
0.93
|
|
33
|
Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome.
|
Clin Infect Dis
|
2000
|
0.93
|
|
34
|
Effect of pristinamycin on cyclosporin levels in bone marrow transplant recipients.
|
Bone Marrow Transplant
|
1989
|
0.92
|
|
35
|
Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus.
|
J Hosp Infect
|
2005
|
0.91
|
|
36
|
Chronic disseminated Trichosporon asahii infection in a leukemic child.
|
Clin Infect Dis
|
2002
|
0.88
|
|
37
|
Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancer.
|
Cancer
|
1988
|
0.87
|
|
38
|
Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors.
|
Anticancer Res
|
2010
|
0.87
|
|
39
|
European expert opinion on the management of invasive candidiasis in adults.
|
Clin Microbiol Infect
|
2011
|
0.87
|
|
40
|
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
|
Transpl Infect Dis
|
2007
|
0.86
|
|
41
|
Prospective study of bacteraemia in cancer patients. Results of a French multicentre study.
|
Support Care Cancer
|
1998
|
0.85
|
|
42
|
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.
|
Clin Microbiol Infect
|
2012
|
0.85
|
|
43
|
A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm.
|
Leukemia
|
2012
|
0.85
|
|
44
|
High incidence but low burden of coronaviruses and preferential associations between respiratory viruses.
|
J Clin Microbiol
|
2013
|
0.84
|
|
45
|
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
|
J Clin Oncol
|
1992
|
0.84
|
|
46
|
Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities.
|
Leukemia
|
2008
|
0.84
|
|
47
|
[Diffuse digestive tract B-cell lymphoma manifesting as exudative enteropathy].
|
Presse Med
|
1998
|
0.84
|
|
48
|
Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).
|
Clin Microbiol Infect
|
2012
|
0.84
|
|
49
|
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.
|
J Clin Oncol
|
2000
|
0.83
|
|
50
|
Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast.
|
Cancer
|
1990
|
0.83
|
|
51
|
An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
|
Eur J Cancer
|
2004
|
0.81
|
|
52
|
Isolated renal Aspergillus abscess in an AIDS patient with a normal CD4+ cell count on highly active antiretroviral therapy.
|
Eur J Clin Microbiol Infect Dis
|
1999
|
0.81
|
|
53
|
Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B.
|
J Antimicrob Chemother
|
2010
|
0.80
|
|
54
|
Malignant thymic lymphoblastic lymphoma and myasthenia gravis: an exceptional association.
|
Nouv Rev Fr Hematol
|
1992
|
0.79
|
|
55
|
Fatal Aspergillus fumigatus Myositis in an immunocompetent patient.
|
Eur J Clin Microbiol Infect Dis
|
2001
|
0.79
|
|
56
|
[Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles].
|
Presse Med
|
1995
|
0.78
|
|
57
|
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.
|
Hematol J
|
2001
|
0.78
|
|
58
|
Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system.
|
J Med Econ
|
2010
|
0.78
|
|
59
|
[Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer].
|
Bull Cancer
|
2000
|
0.77
|
|
60
|
Waldenström's macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders.
|
Blood Cancer J
|
2012
|
0.77
|
|
61
|
Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review.
|
Nouv Rev Fr Hematol
|
1991
|
0.77
|
|
62
|
Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas.
|
Leukemia
|
2013
|
0.77
|
|
63
|
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
|
J Clin Oncol
|
1996
|
0.77
|
|
64
|
Post-traumatic intracranial epidural Aspergillus fumigatus abscess.
|
J Med Vet Mycol
|
1997
|
0.76
|
|
65
|
Safety and efficacy of Intralipid emulsions of amphotericin B.
|
J Antimicrob Chemother
|
1997
|
0.76
|
|
66
|
Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients.
|
Bone Marrow Transplant
|
1994
|
0.76
|
|
67
|
[New lipid formulations of amphotericin B. Review of the literature].
|
Rev Med Interne
|
2001
|
0.76
|
|
68
|
[Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].
|
Nouv Rev Fr Hematol
|
1994
|
0.76
|
|
69
|
Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
|
Bone Marrow Transplant
|
1996
|
0.76
|
|
70
|
Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMT.
|
Bone Marrow Transplant
|
2011
|
0.76
|
|
71
|
Effects of bacterial naso-oropharyngeal colonisation on acute graft-versus-host disease in patients undergoing allogeneic bone marrow transplantation.
|
Bone Marrow Transplant
|
1995
|
0.76
|
|
72
|
[Renal clear-cell adenocarcinoma and type B lymphomatous proliferation: a fortuitous association?].
|
Rev Med Interne
|
1999
|
0.75
|
|
73
|
Interactions of cyclosporine with antimicrobial agents.
|
Rev Infect Dis
|
1990
|
0.75
|
|
74
|
Primary hepatic lymphoma associated with chronic hepatitis C.
|
Ann Med Interne (Paris)
|
1997
|
0.75
|
|
75
|
Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia.
|
Cancer Genet Cytogenet
|
1999
|
0.75
|
|
76
|
[A cytological, immunophenotypical and cytogenetical study of 136 consecutive cases of B-cell chronic lymphoid hemopathies].
|
Pathol Biol (Paris)
|
2006
|
0.75
|
|
77
|
[Inhibition of poly-ADP-ribose synthetase, a new approach in research on the reduction of cellular proliferation].
|
Bull Acad Natl Med
|
1983
|
0.75
|
|
78
|
Idarubicin and high dose cytarabine: a new salvage treatment for refractory or relapsing non-Hodgkin's lymphoma.
|
Leuk Lymphoma
|
1996
|
0.75
|
|
79
|
High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual disease.
|
Eur J Gynaecol Oncol
|
1991
|
0.75
|
|
80
|
Achievements and goals of the EORTC Invasive Fungal Infections Group. European Organisation for Research and Treatment of Cancer.
|
Eur J Cancer
|
2002
|
0.75
|
|
81
|
Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: a pilot study.
|
Gynecol Oncol
|
1998
|
0.75
|
|
82
|
[Capillary hyperpermeability syndrome of the face].
|
Presse Med
|
2000
|
0.75
|
|
83
|
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
|
Med Mal Infect
|
2013
|
0.75
|
|
84
|
Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients.
|
Prog Clin Biol Res
|
1990
|
0.75
|
|
85
|
Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" study.
|
Cancer Detect Prev
|
1996
|
0.75
|
|
86
|
[Therapeutic aspects in the management of hairy cell leukemia].
|
Presse Med
|
1999
|
0.75
|
|
87
|
Intraperitoneal mitoxantrone as consolidation treatment for stage III ovarian carcinoma: a pilot study.
|
Bull Cancer
|
1991
|
0.75
|
|
88
|
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.
|
Ann Oncol
|
1996
|
0.75
|
|
89
|
[Acute myeloblastic leukemias and myelodysplasias: treatment with low doses of aracytine].
|
Nouv Rev Fr Hematol
|
1986
|
0.75
|
|
90
|
[Results of cisplatin-based polychemotherapy and analysis of prognostic factors in ovarian cancer. Apropos of 106 cases].
|
Bull Cancer
|
1989
|
0.75
|
|
91
|
[Treatment of aggressive primary lymphomas of the digestive system by intensive chemotherapy. Experience of the Study Group on Lymphomas in Adults with the LNH-84 protocol].
|
Ann Gastroenterol Hepatol (Paris)
|
1992
|
0.75
|
|
92
|
Hearing loss due to acute leukemia.
|
Am J Med
|
2000
|
0.75
|
|
93
|
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte.
|
Cancer
|
1998
|
0.75
|
|
94
|
[Pseudotumoral pneumocystosis: one case and a review of the literature].
|
Rev Pneumol Clin
|
1989
|
0.75
|